A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty

Department of Medicine, New York Hospital-Cornell Medical Center, New York 10021.

OBJECTIVES. A new percutaneous collagen hemostasis device was compared with conventional compression techniques after diagnostic catheterization and angioplasty. BACKGROUND. Peripheral vascular complications after diagnostic catheterization or more complex interventional procedures, as well as the discomfort of manual compression and prolonged bed rest, represent significant morbidity for invasive cardiac procedures. METHODS. A prospective, multicenter, randomized trial was designed to compare the hemostasis time in minutes and the incidence of vascular complications in patients receiving a vascular hemostasis device with those undergoing conventional compression techniques. RESULTS. After diagnostic catheterization, hemostasis time was significantly less with the vascular hemostasis device than with conventional manual compression (4.1 +/- 2.8 min [n = 90 patients] vs. 17.6 +/- 9.2 min [n = 75], p < 0.0001). This difference was greater in patients undergoing angioplasty and was unrelated to the anticoagulation status (4.3 +/- 3.7 min [n = 71 not receiving heparin], 7.6 +/- 11.6 min [n = 85 receiving heparin], 33.6 +/- 24.2 min [n = 134 control patients not receiving heparin], p < 0.0001 vs. control patients). The time from the start of the procedure to ambulation was slightly less after diagnostic catheterization in patients treated with the device (13.3 +/- 12.1 h vs. 19.2 +/- 17.8 h, p < 0.05). It was also less in patients who underwent angioplasty when the device was used after discontinuation of anticoagulation (23.0 +/- 11.1 h, without heparin), as compared with control compression techniques (32.7 +/- 18.8 h, p < 0.0001). Time to ambulation was even shorter (16.1 +/- 11.1 h, p < 0.0001) in patients in whom the device was placed immediately after angioplasty while they were still fully anticoagulated with a prolonged activated clotting time (336 +/- 85 s). There were no major complications (surgery or transfusion) after diagnostic catheterization and a low incidence of major complications in patients who underwent angioplasty (0.7% in control patients, 1.4% with the device without heparin, 1.2% with the device and heparin, p = NS). After angioplasty, there was a trend toward fewer hematomas when the device was used in the absence of heparin (4.2% vs. 9.7% in control patients, p = 0.14). CONCLUSIONS. A new vascular hemostasis device can significantly reduce the puncture site hemostasis time and the time to ambulation without significantly increasing the risk of peripheral vascular complications. The role of this technology in reducing complications, length of hospital stay and cost remains to be determined.

This article has been cited by other articles:

				A. Rodriguez and S. G. Katz The Use of the Starclose Device for Obtaining Femoral Artery Hemostasis Vascular and Endovascular Surgery, October 1, 2011; 45(7): 627 - 630. [Abstract] [PDF]

				M. R. Patel, H. Jneid, C. P. Derdeyn, L. W. Klein, G. N. Levine, R. A. Lookstein, C. J. White, Y. Yeghiazarians, K. Rosenfield, and on behalf of the American Heart Association Diagno Arteriotomy Closure Devices for Cardiovascular Procedures: A Scientific Statement From the American Heart Association Circulation, November 2, 2010; 122(18): 1882 - 1893. [Full Text] [PDF]

				T. A. Sanborn, R. Ebrahimi, S. V. Manoukian, B. T. McLaurin, D. A. Cox, F. Feit, M. Hamon, R. Mehran, and G. W. Stone Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial Circ Cardiovasc Interv, February 1, 2010; 3(1): 57 - 62. [Abstract] [Full Text] [PDF]

				H. L. Dauerman, R. J. Applegate, and D. J. Cohen Vascular Closure Devices: The Second Decade J. Am. Coll. Cardiol., October 23, 2007; 50(17): 1617 - 1626. [Abstract] [Full Text] [PDF]

				The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]

				E. Nikolsky, R. Mehran, A. Halkin, E. D. Aymong, G. S. Mintz, Z. Lasic, M. Negoita, M. Fahy, S. Krieger, I. Moussa, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1200 - 1209. [Abstract] [Full Text] [PDF]

				M. Koreny, E. Riedmuller, M. Nikfardjam, P. Siostrzonek, and M. Mullner Arterial Puncture Closing Devices Compared With Standard Manual Compression After Cardiac Catheterization: Systematic Review and Meta-analysis JAMA, January 21, 2004; 291(3): 350 - 357. [Abstract] [Full Text] [PDF]

				G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and Management of Patients Undergoing Percutaneous Coronary Revascularization Ann Intern Med, July 15, 2003; 139(2): 123 - 136. [Abstract] [Full Text] [PDF]

				R. J. Applegate, M. A. Grabarczyk, W. C. Little, T. Craven, M. Walkup, F. R. Kahl, G. A. Braden, K. M. Rankin, and M. A. Kutcher Vascular closure devices in patients treated with anticoagulation and iib/iiia receptor inhibitors during percutaneous revascularization J. Am. Coll. Cardiol., July 3, 2002; 40(1): 78 - 83. [Abstract] [Full Text] [PDF]

				S. L. Meyerson, T. Feldman, T. R. Desai, J. Leef, L. B. Schwartz, and J. F. Mckinsey Anglographic Access Site Complications in the Era of Arterial Closure Devices Vascular and Endovascular Surgery, March 1, 2002; 36(2): 137 - 144. [Abstract] [PDF]

				G. Dangas, R. Mehran, S. Kokolis, D. Feldman, L. F. Satler, A. D. Pichard, K. M. Kent, A. J. Lansky, G. W. Stone, and M. B. Leon Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices J. Am. Coll. Cardiol., September 1, 2001; 38(3): 638 - 641. [Abstract] [Full Text] [PDF]

				D. Tavris, T. Gross, B. Gallauresi, and L. Kessler Arteriotomy closure devices--the FDA perspective J. Am. Coll. Cardiol., September 1, 2001; 38(3): 642 - 644. [Full Text] [PDF]

				S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]

				M. Rabah, D. Mason, D. W. M. Muller, R. Hundley, A. D. Kugelmass, B. Weiner, L. Cannon, W. W. O'Neill, and R. D. Safian Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention J. Am. Coll. Cardiol., August 1, 1999; 34(2): 461 - 467. [Abstract] [Full Text] [PDF]

				S. H. Duda, J. Wiskirchen, M. Erb, U. Schott, K. Khaligi, P. L. Pereira, J. Albes, and C. D. Claussen Suture-mediated Percutaneous Closure of Antegrade Femoral Arterial Access Sites in Patients Who Have Full Anticoagulation Therapy Radiology, January 1, 1999; 210(1): 47 - 52. [Abstract] [Full Text]

				D. J. Cohen, H. M. Krumholz, C. A. Sukin, K. K.L. Ho, R. B. Siegrist, M. Cleman, R. R. Heuser, J. A. Brinker, J. W. Moses, M. P. Savage, et al. In-Hospital and One-Year Economic Outcomes After Coronary Stenting or Balloon Angioplasty : Results From a Randomized Clinical Trial Circulation, November 1, 1995; 92(9): 2480 - 2487. [Abstract] [Full Text]

				S. G. Ellis, D. P. Miller, K. J. Brown, N. Omoigui, G. L. Howell, M. Kutner, and E. J. Topol In-Hospital Cost of Percutaneous Coronary Revascularization : Critical Determinants and Implications Circulation, August 15, 1995; 92(4): 741 - 747. [Abstract] [Full Text]